Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015Alan S. Coates, Binghe Xu, Andrew Tutt et al.|Annals of Oncology|2015Cited by 1.8k
A SUMOylation-Dependent Transcriptional Subprogram Is Required for Myc-Driven TumorigenesisJessica D. Kessler, Thomas F. Westbrook, Kristopher T. Kahle et al.|Science|2011Cited by 440
Activation of Multiple Proto-oncogenic Tyrosine Kinases in Breast Cancer via Loss of the PTPN12 PhosphataseTingting Sun, Thomas F. Westbrook, Nicola Aceto et al.|Cell|2011Cited by 276
Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancerChad J. Creighton, Rachel Schiff, Xiaoyong Fu et al.|Breast Cancer Research|2010Cited by 258
Biological mechanisms and clinical implications of endocrine resistance in breast cancerMario Giuliano, Meghana V. Trivedi, Rachel Schiff et al.|The Breast|2011Cited by 111